Mark Cuban and Ted Cruz battle it out on Twitter, South Korea releases a study on back-to-school, and LeBron James’ rookie card sets a new auction record. Here are the stories shaping sports and business on Monday, July 20.
Mark Cuban Takes on Ted Cruz
Dallas Mavericks owner Mark Cuban took a stand on Twitter regarding players and professional athletes standing or kneeling during the national anthem. Cuban tweeted, "The National Anthem Police in this country are out of control. If you want to complain, complain to your boss and ask why they don't play the National Anthem every day before you start work.”
Cuban’s social media post caught the attention of Texas Senator Ted Cruz who responded, "Really??!? NBA is telling everyone who stands for the flag, who honors our cops and our veterans, to ‘piss off’? In Texas, no less? Good luck with that.”
Cuban responded with some choice words for Cruz, calling out the Senator for sub-tweeting him instead of responding to Cuban directly. It’s a fairly long exchange between the politician and the successful businessman.
There are 14.5 million cases of the coronavirus worldwide, with over 607,000 deaths. The U.S. has over 3.7 million cases with over 140,000 deaths.
There’s a new study out from South Korea which offers some answers to the questions around kids returning back to school and what could happen. The study found that children under 10 transmit the virus at nearly half the rate that adults do. However, children aged 10 to 19 can spread the virus at the same rate as adults. This is one the largest studies of its kind and overall suggests that kids going back to school could lead to clusters of outbreaks in communities in both children and adults.
President Donald Trump is resurrecting the White House coronavirus task force briefings. This comes as the U.S. Senate returned on Monday to start negotiations on the next economic package to help the economy weather the ongoing pandemic. This comes as the Pandemic Unemployment Assistance program, which puts an extra $600 in the pockets of millions of Americans who have filed for unemployment during the pandemic, is set to end at the end of the week.
On Monday, AstraZeneca and Oxford University released new information about their coronavirus vaccine candidate. The data looks promising from the early-stage trial of a key coronavirus vaccine study in London that could lead to its broader use before the end of the year. The details, published in the U.K. medical journal The Lancet, showed what the two groups described as humoral and cellular immune responses in human trials, with an acceptable safety profile. The study also showed 'potent' cellular and humoral immunogenicity in all 1,077 participants in the Phase 1/Phase II study. “The immune responses observed following vaccination are in line with what we expect will be associated with protection against the SARS-CoV-2 virus, although we must continue with our rigorous clinical trial program to confirm this,” said Andrew Pollard, chief investigator of the Oxford Vaccine Trial at Oxford University and co-author of the trial.
LeBron James’ Rookie Card Goes for Over $1 Million
The sports card industry is seeing massive growth in popularity and on Sunday, a LeBron James rookie card was auctioned off for an eye-popping $1.8 million, making it the highest amount paid for a sports card of a modern-day player.
The card is autographed by LeBron James and includes a piece of cloth from one of his jerseys. Only 23 of those cards were made.
Vayner Media CEO Gary Vaynerchuck has been touting the explosion of the sports card industry, which appears to quickly be going mainstream.
Latest Videos From TheStreet and Jim Cramer:
- Why Jim Cramer Is Closely Eyeing IBM Earnings
- Jim Cramer: Economy Will Lose Momentum Without More Stimulus
- Jim Cramer: eBay Stock Is Going to Go Higher
- What's Next for Apple and the EU?
- Tesla Reports Earnings: Here's What to Expect
- What Is Trump’s Economic Plan and How Will it Impact Stocks?
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- Coronavirus Update: Pfizer to Supply 30 Million Vaccine Doses to U.K.